BackCompugen Overview
Compugen Ltd

Compugen Target Price

See Compugen's analyst price targets ($5) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$2.38

Average Target Price

$5.00110.1% upside

1 analysts in the last 4 months

High: $5 | Low: $5

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-21Leerink Partners$5110.1% upsideOpen
2026-01-07H.C. Wainwright$468.1% upsideOpen
2024-05-21Truist FinancialAsthika Goonewardene$468.1% upsideOpen
2024-05-20Stifel NicolausStephen Willey$468.1% upsideOpen
2024-05-20Truist FinancialAsthika Goonewardene$5110.1% upsideOpen

Compugen (CGEN) FAQ

As of the most recent data, CGEN shows a target price of $5. Scroll down for historical charts and peer comparison views.

If Compugen moved to the average analyst target of $5, shares would be roughly 110.1% higher than $2.38. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Compugen's earnings trajectory.

Besides this target price page, Stockcircle has Compugen's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $5) with ownership activity and broader fundamentals.

Compugen's target price is $5; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.